Epilepsy Drug May Offer Relief for Sleep Apnea Sufferers




Imagine a world where you could trade in your CPAP machine for a daily pill. For those who struggle with the disruptive symptoms of sleep apnea, that dream may soon become a reality. Researchers have discovered that an existing epilepsy drug, sulthiame, has shown promising results in alleviating sleep apnea symptoms.
Sulthiame, sold under the brand name Ospolot in Europe, has been used for decades to treat seizures. However, a recent international study revealed that this medication may also have the ability to significantly reduce the symptoms of obstructive sleep apnea (OSA).
How Does It Work?
OSA is characterized by repeated episodes of breathing pauses during sleep, leading to fragmented and unrefreshing slumber. Sulthiame is believed to work by relaxing the upper airway muscles, preventing them from collapsing and causing airway obstruction.
Promising Results
The study, published in the journal *Neurology*, involved over 200 adults with OSA. Participants taking sulthiame experienced a reduction in OSA symptoms by about 50%, including a significant decrease in the number of breathing pauses per hour. They also reported improved sleep quality and reduced daytime sleepiness.
A Welcome Alternative
For many people with OSA, CPAP therapy is the standard treatment. However, it can be uncomfortable, noisy, and difficult to tolerate. Sulthiame offers a potential alternative for those who struggle with CPAP adherence or who prefer a non-invasive treatment option.
Next Steps
While the findings are encouraging, more research is needed to confirm the long-term effects of sulthiame on OSA symptoms. The study also did not examine whether sulthiame can prevent the development of cardiovascular complications associated with OSA, such as heart attack and stroke.
A Glimmer of Hope
For millions who suffer from sleep apnea, the possibility of a simple, effective treatment is a glimmer of hope. Sulthiame may not be a cure-all, but it offers a promising avenue for improving sleep quality and overall well-being for those affected by this common sleep disorder.